Anti-trypanosomal peptides and uses thereof
View Patent ↗The present invention provides methods of killing, inhibiting the growth, and/or inhibiting the reproduction of kinetoplastid protozoan with hydrophobic signal sequence peptides and compositions including such hydrophobic signal sequence peptides.
1. A method of inducing rigidification of the plasma membrane of a bloodstream form of a kinetoplastid protozoan of the genus Trypanosoma , the method comprising contacting the protozoan with an isolated hydrophobic signal sequence peptide, wherein the isolated hydrophobic signal sequence peptide consists of 17 to 25 amino acid residues of an uncleaved, hydrophobic N-terminal signal sequence, wherein the isolated hydrophobic signal sequence peptide contains a positively charged amino acid at position minus five relative to the C-terminus of the hydrophobic signal sequence peptide, and wherein the hydrophobic signal sequence peptide comprises at least nine consecutive amino acid residues of MSDLGAVISLLLWGRQLFA, SEQ ID NO:1 or a derivative of SEQ ID NO:1, wherein the derivative of SEQ ID NO:1 has up to four hydrophobic amino acid residues of SEQ ID NO:1 exchanged for another hydrophobic amino acid, and/or one positively charged amino acid residues of SEQ ID NO:1 exchanged for another positively charged amino acid.
2. The method of claim 1 , wherein the hydrophobic signal sequence peptide is soluble in ethanol or dimethyl sulfoxide (DMSO).
3. A method of inducing rigidification of the plasma membrane of a bloodstream form of a kinetoplastid protozoan of the genus Trypanosoma , the method comprising contacting the protozoan with an isolated hydrophobic signal sequence peptide, wherein the isolated hydrophobic signal sequence peptide consists of 17 to 25 amino acid residues of an uncleaved, hydrophobic N-terminal signal sequence, wherein the isolated hydrophobic signal sequence peptide contains a positively charged amino acid at position minus five relative to the C-terminus of the hydrophobic signal sequence peptide, and wherein the hydrophobic signal sequence peptide comprises at least nine consecutive amino acid residues of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:7, SEQ ID NO:15, SEQ ID NO:16 or SEQ ID NO:17.
4. The method of claim 1 , wherein the trypanosome is selected from the group consisting of Trypanosoma brucei brucei, T. b. gambiense , and T. b. rhodesiense, T. congolense , and T. vivax.
5. The method of claim 1 , wherein the hydrophobic signal sequence peptide is provided as a composition further comprising liposome, emulsion, or micelle.
6. The method of claim 1 , wherein the hydrophobic signal sequence peptide is provided as a composition further comprising an RNA aptamer that binds to a structurally conserved region of a trypanosome variant surface glycoprotein (VSG).
7. The method of claim 1 , wherein the hydrophobic signal sequence peptide is provided as a pyrogen-free composition.
8. The method of claim 1 , wherein the plasma membrane rigidification results in killing, inhibition of growth, inhibition of reproduction, plasma membrane degradation, and/or constricted cell motility of the bloodstream form of a kinetoplastid protozoan of the genus Trypanosoma.
9. The method of claim 1 wherein contacting the protozoan with a hydrophobic signal sequence peptide comprises in vitro, ex vivo, or in vivo contact.
10. The method of claim 9 comprising in vivo contact within the body of a mammalian subject.
11. A method of inducing rigidification of the plasma membrane of a bloodstream form of a kinetoplastid protozoan of the genus Trypanosoma , the method comprising contacting the protozoan with an isolated hydrophobic signal sequence peptide, wherein the isolated hydrophobic signal sequence peptide is selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:7, SEQ ID NO:15, SEQ ID NO:16 and SEQ ID NO:17.
12. A method of inducing rigidification of the plasma membrane of a bloodstream form of a kinetoplastid protozoan of the genus Trypanosoma , the method comprising contacting the protozoan with an isolated trypanocidal peptide of 12 to 25 amino acid residues in length, wherein the isolated trypanocidal peptide comprises at least nine consecutive amino acid residues of MSDLGAVISLLLWGRQLFA, SEQ ID NO:1 or a derivative of SEQ ID NO:1, wherein the derivative of SEQ ID NO:1 has up to four hydrophobic amino acid residues of SEQ ID NO:1 exchanged for another hydrophobic amino acid, and/or one positively charged amino acid residues of SEQ ID NO:1 exchanged for another positively charged amino acid.
13. The method of claim 3 , wherein the plasma membrane rigidification results in killing, inhibition of growth, inhibition of reproduction, plasma membrane degradation, and/or constricted cell motility of the bloodstream form of a kinetoplastid protozoan of the genus Trypanosoma.
14. The method of claim 3 , wherein the trypanosome is selected from the group consisting of Trypanosoma brucei brucei, T. b. gambiense , and T. b. rhodesiense, T. congolense , and T. vivax.
15. The method of claim 3 , wherein the hydrophobic signal sequence peptide is provided as a composition further comprising liposome, emulsion, or micelle.
16. The method of claim 3 , wherein the hydrophobic signal sequence peptide is provided as a composition further comprising an RNA aptamer that binds to a structurally conserved region of a trypanosome variant surface glycoprotein (VSG).
17. The method of claim 3 , wherein the hydrophobic signal sequence peptide is soluble in ethanol or dimethyl sulfoxide (DMSO).
18. The method of claim 3 , wherein the hydrophobic signal sequence peptide is provided as a pyrogen-free composition.
19. The method of claim 3 , wherein contacting the protozoan with a hydrophobic signal sequence peptide comprises in vitro, ex vivo, or in vivo contact.
20. The method of claim 19 comprising in vivo contact within the body of a mammalian subject.
21. The method of claim 11 , wherein the plasma membrane rigidification results in killing, inhibition of growth, inhibition of reproduction, plasma membrane degradation, and/or constricted cell motility of the bloodstream form of a kinetoplastid protozoan of the genus Trypanosoma.
22. The method of claim 11 , wherein the trypanosome is selected from the group consisting of Trypanosoma brucei brucei, T. b. gambiense , and T. b. rhodesiense, T. congolense , and T. vivax.
23. The method of claim 11 , wherein the hydrophobic signal sequence peptide is provided as a composition further comprising liposome, emulsion, or micelle.
24. The method of claim 11 , wherein the hydrophobic signal sequence peptide is provided as a composition further comprising an RNA aptamer that binds to a structurally conserved region of a trypanosome variant surface glycoprotein (VSG).
25. The method of claim 11 , wherein the hydrophobic signal sequence peptide is soluble in ethanol or dimethyl sulfoxide (DMSO).
26. The method of claim 11 , wherein the hydrophobic signal sequence peptide is provided as a pyrogen-free composition.
27. The method of claim 11 , wherein contacting the protozoan with a hydrophobic signal sequence peptide comprises in vitro, ex vivo, or in vivo contact.
28. The method of claim 27 comprising in vivo contact within the body of a mammalian subject.
29. The method of claim 12 , wherein the plasma membrane rigidification results in killing, inhibition of growth, inhibition of reproduction, plasma membrane degradation, and/or constricted cell motility of the bloodstream form of a kinetoplastid protozoan of the genus Trypanosoma.
30. The method of claim 12 , wherein the trypanosome is selected from the group consisting of Trypanosoma brucei brucei, T. b. gambiense , and T. b. rhodesiense, T. congolense , and T. vivax.
31. The method of claim 12 , wherein the hydrophobic signal sequence peptide is provided as a composition further comprising liposome, emulsion, or micelle.
32. The method of claim 12 , wherein the hydrophobic signal sequence peptide is provided as a composition further comprising an RNA aptamer that binds to a structurally conserved region of a trypanosome variant surface glycoprotein (VSG).
33. The method of claim 12 , wherein the hydrophobic signal sequence peptide is soluble in ethanol or dimethyl sulfoxide (DMSO).
34. The method of claim 12 , wherein the hydrophobic signal sequence peptide is provided as a pyrogen-free composition.
35. The method of claim 12 , wherein contacting the protozoan with a hydrophobic signal sequence peptide comprises in vitro, ex vivo, or in vivo contact.
36. The method of claim 35 comprising in vivo contact within the body of a mammalian subject.